Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rationale for combination therapy.

L Hansson

    British Journal of Clinical Pharmacology
    |January 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Treated hypertensive patients experience higher cardiovascular risks. Achieving normotensive blood pressure levels through combination therapy, such as ACE-inhibitors with diuretics or calcium antagonists, is crucial for better outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.

    Lancet (London, England)·2000
    Same author

    Operations for extrahepatic bile duct cancers: are the results really improving?

    The European journal of surgery = Acta chirurgica·2000
    Same author

    Blood pressure @ Internet-www.bloodpressure.nu.

    Blood pressure·2000
    Same author

    Study on COgnition and Prognosis in the Elderly (SCOPE): baseline characteristics.

    Blood pressure·2000
    Same author

    Endothelial dysfunction--a challenge for hypertension research.

    Blood pressure·2000
    Same author

    Introduction: the role of combination therapy in modern antihypertensive therapy.

    Journal of cardiovascular pharmacology·2000
    Same journal

    N-acetylcysteine for non-paracetamol-induced acute liver failure in children: A systematic review and meta-analysis.

    British journal of clinical pharmacology·2026
    Same journal

    Anti-seizure medications and DRESS in paediatric patients: A FAERS disproportionality and time-to-onset analysis.

    British journal of clinical pharmacology·2026
    Same journal

    Modelling immune gene expression profiles as pharmacodynamic endpoints of antileishmanial treatment.

    British journal of clinical pharmacology·2026
    Same journal

    The effect of mild and moderate hepatic impairment on the pharmacokinetics, safety and tolerability of balcinrenone.

    British journal of clinical pharmacology·2026
    Same journal

    Relationship between continuous infusion meropenem PK/PD target attainment and C-reactive protein dynamics in onco-haematologic patients with febrile neutropenia.

    British journal of clinical pharmacology·2026
    Same journal

    UGT1A1 genotype testing for irinotecan: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx).

    British journal of clinical pharmacology·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Hypertension management remains a significant challenge in cardiovascular health.
    • Treated hypertensive patients exhibit higher cardiovascular morbidity and mortality compared to normotensive individuals.
    • Elevated arterial pressure in treated hypertensive patients may contribute to adverse outcomes.

    Purpose of the Study:

    • To investigate the rationale for setting therapeutic goals in hypertension treatment.
    • To explore the necessity of combination therapy for achieving normotensive blood pressure levels.
    • To evaluate specific antihypertensive drug combinations for efficacy and tolerability.

    Main Methods:

    • Review of existing literature on hypertension treatment and outcomes.
    • Analysis of factors contributing to cardiovascular risk in treated hypertensive patients.

    Related Experiment Videos

  • Evaluation of combined drug therapies for hypertension management.

    • Main Results:

    • Cardiovascular risks are elevated in treated hypertensive patients.
    • Normotensive blood pressure levels are identified as a key therapeutic goal.
    • Combined antihypertensive drug regimens are suggested as necessary to achieve treatment goals.

    Conclusions:

    • Achieving normotensive blood pressure is essential for reducing cardiovascular risks in hypertensive patients.
    • Combination therapy, specifically ACE-inhibitors with diuretics or calcium antagonists, shows promise for potent antihypertensive efficacy and good tolerability.